ライフサイエンスコーパス: thyroidectomy

1 al disease, and one-stage or two-stage total thyroidectomy).

2 oactive iodine (RAI), or surgery (near-total thyroidectomy).

3 e of undiagnosed cancer requiring completion thyroidectomy.

4 versial and ranges from observation to total thyroidectomy.

5 Use of radioactive iodine after total thyroidectomy.

6 e of the most common complications following thyroidectomy.

7 izing postoperative hypocalcemia after total thyroidectomy.

8 4 cm should be considered for initial total thyroidectomy.

9 yroid drugs, radioactive iodine ablation, or thyroidectomy.

10 oid carcinoma five or more years after total thyroidectomy.

11 The fifth lesion was found to be benign at thyroidectomy.

12 ion characteristic of MEN-2A underwent total thyroidectomy.

13 All patients had undergone total thyroidectomy.

14 Each patient previously had a near-total thyroidectomy.

15 sts before, 1 week after, and 3 months after thyroidectomy.

16 tients, who then underwent a one-stage total thyroidectomy.

17 ersistently elevated calcitonin levels after thyroidectomy.

18 ar extension) showed no benefit over partial thyroidectomy.

19 th complication rates and length of stay for thyroidectomy.

20 rathyroidism is a recognized complication of thyroidectomy.

21 and residual activity in the neck following thyroidectomy.

22 oid glands resected or devascularized during thyroidectomy.

23 lcemia is the most common complication after thyroidectomy.

24 gnosed with anaplastic thyroid cancer at the thyroidectomy.

25 surgical procedures of the neck, especially thyroidectomy.

26 ients were included, of whom 338 (98%) had a thyroidectomy.

27 ts who were undergoing a total or completion thyroidectomy.

28 mmon complications after total or completion thyroidectomy.

29 ice dysfunction rates in patients undergoing thyroidectomy.

30 gnosis is often still established only after thyroidectomy.

31 enetic testing are candidates for preventive thyroidectomy.

32 tracked for 6 or more months after oncologic thyroidectomy.

33 oblem that commonly occurs in patients after thyroidectomy.

34 es treatment with antithyroid drugs, RAI, or thyroidectomy.

35 mical measure to reduce PONV incidence after thyroidectomy.

36 ndations for safe, effective and appropriate thyroidectomy.

37 roidectomy, and 3 patients received subtotal thyroidectomy.

38 e should be an absolute indication for total thyroidectomy.

39 reducing the need for diagnostic lobectomies/thyroidectomies.

40 having either total, subtotal, or completion thyroidectomy, 104 (54%) experienced a [Ca(+2)]nadir les

41 5.0%]; OR, 0.34; 95% CI, 0.27-0.43), partial thyroidectomies (14 [1.6%] vs 424 [4.0%]; OR, 0.39; 95%

42 gastrectomy (54%), pancreatectomy (31%), and thyroidectomy (23%).

43 A 67-yr-old woman who underwent total thyroidectomy 32 yr ago developed accelerated hyperthyro

44 In the first 24 hours after undergoing thyroidectomy, 47 patients (24.4%) developed hypocalcemi

45 Among 16,954 patients undergoing total thyroidectomy, 47% had thyroid cancer and 53% benign dis

46 patient group was 82% in patients with total thyroidectomy, 78% in patients with subtotal thyroidecto

47 ents with low-risk thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve

48 ly, in tumor burden or stage, or in the post-thyroidectomy ablation rate (group 1, 81%; group 2, 74%;

49 onwide inpatient sample was used to identify thyroidectomy admissions from 1999 to 2004, using ICD-9

50 In the other 318 patients who underwent thyroidectomy after 1 year of age, biochemical and struc

51 ble analysis, compared with those undergoing thyroidectomy alone, RAI treatment was associated with a

52 justment for potential confounders, surgical thyroidectomy, alone or in combination with medical ther

53 ) performed the greatest proportion of total thyroidectomies among the 5860 discharges, and they were

54 ases of permanent hypoparathyroidism per 100 thyroidectomies and 0.99 to 2.13 cases of recurrent lary

55 ferentiated thyroid cancer who had undergone thyroidectomy and ( 131)I ablation, posttherapy ( 131)I

56 61,775 PTC patients, 54,926 underwent total thyroidectomy and 6849 lobectomy.

57 Total thyroidectomy and central neck dissection followed by ra

58 tation informs the age at which prophylactic thyroidectomy and diagnostic screening for MEN-associate

59 determine severe hypocalcemia rate following thyroidectomy and factors associated with its occurrence

60 ment, and a malignant nodule, which requires thyroidectomy and further treatment.

61 ) is the most common complication post-total thyroidectomy and is associated with increased morbidity

62 based on whether they had undergone previous thyroidectomy and on the results of standardized staging

63 toperative management in most patients after thyroidectomy and parathyroid autotransplantation involv

64 Children undergoing thyroidectomy and parathyroidectomy have higher complica

65 Complications following thyroidectomy and parathyroidectomy in children can have

66 ndocrine surgeons in 102 patients undergoing thyroidectomy and parathyroidectomy procedures.

67 cioeconomic disparities in adults undergoing thyroidectomy and parathyroidectomy.

68 Early vocal symptoms are common following thyroidectomy and persist in 14% of patients.

69 After thyroidectomy and radioiodine ablation, thyroglobulin be

70 astasis despite initial treatment with total thyroidectomy and RAI ablation.

71 itial treatments: 46 patients received total thyroidectomy and RAI, 3 patients received total thyroid

72 tal of 116 patients with PTC underwent total thyroidectomy and routine prophylactic CND at a tertiary

73 Patients who underwent thyroidectomy and sentinel lymph node biopsy for papilla

74 An analysis of 194 patients having thyroidectomy and simultaneous parathyroid autotransplan

75 ctive studies can confirm our finding that a thyroidectomy and statin use are associated with substan

76 C patients who underwent total or near-total thyroidectomy and subsequent (131)I treatment after levo

77 induced to express 100% beta-MHC by surgical thyroidectomy and subsequent treatment with propylthiour

78 ersistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the ce

79 therapy, patients are first treated by total thyroidectomy and then allowed to become hypothyroid.

80 nsive lymphadenectomy at the time of initial thyroidectomy and to consider reoperative cervical lymph

81 uded patients undergoing total or completion thyroidectomy and was conducted at a single academic cen

82 Because one patient had undergone total thyroidectomy and was excluded from the study, a retrosp

83 ent of patients who have not had an adequate thyroidectomy and who are poor candidates for reoperatio

84 tly used therapies--antithyroid medications, thyroidectomy, and (131)I treatment--are presented.

85 oidectomy and RAI, 3 patients received total thyroidectomy, and 3 patients received subtotal thyroide

86 thyroidectomy, 78% in patients with subtotal thyroidectomy, and 89% in patients with lobectomy (p = 0

87 173 patients, 43,227 (82.9%) underwent total thyroidectomy, and 8946 (17.1%) underwent lobectomy.

88 are commonly found in the thyroid bed after thyroidectomy, and most are likely to be benign.

89 greater than 45 y, the female sex, subtotal thyroidectomy, and RAI-avid diffuse bilateral pulmonary

90 Hypothyroidism was achieved by thyroidectomy, and the 'intruder' stress was used as a m

91 riant carriers (166 [98.2%]) did not undergo thyroidectomy, and their all-cause mortality by age 75 y

92 cular thyroid tumors could avert over 14,000 thyroidectomies annually in the United States, thereby s

93 and suboptimal hypocalcemia management after thyroidectomy are common.

94 servation of parathyroid glands (PTG) during thyroidectomy are crucial for minimizing postoperative c

95 Hypoparathyroidism post-thyroidectomy arises when all parathyroid glands are dev

96 nical guidelines analyze the indications for thyroidectomy as well as its definitions, technique, mor

97 ients who carry this mutation can be offered thyroidectomy at a very young age, hopefully at a point

98 differentiated thyroid cancer who underwent thyroidectomy at multiple centers.

99 ished that strengthen the argument for total thyroidectomy at the time of diagnosis, followed by admi

100 and the present, we performed 102 preventive thyroidectomies attempting to preserve the parathyroid g

101 There are strong proponents for total thyroidectomy based on its presumed and theoretical dise

102 on controversial topics, including extent of thyroidectomy based on tumor size, prophylactic central

103 fine needle aspiration (FNA) biopsy require thyroidectomy because of a 20% to 30% risk of thyroid ca

104 ission status between patients who underwent thyroidectomy before and after the age of 1 year (p<0.00

105 ission status between patients who underwent thyroidectomy before and after the age of 1 year (p<0.00

106 rent disease in children who underwent total thyroidectomy before eight years of age and in children

107 nificant difference between patients who had thyroidectomy before or after 1 year (comparison of surv

108 no previous surgery; group 2 (13) underwent thyroidectomy before referral and had an elevated calcit

109 stant metastases; and group 3 (16) underwent thyroidectomy before referral and had an elevated calcit

110 ocrine symptoms and also recommendations for thyroidectomy before the age of 1 year.

111 d on whether the patient had undergone early thyroidectomy before the age of 1 year.

112 hospital with thyroid cancer and underwent a thyroidectomy between 2001 and 2011 in Massachusetts (n

113 e review of outcomes for patients undergoing thyroidectomy between January 2016 and July 2023 at an a

114 (N = 671) with nonmalignant cytology who had thyroidectomy between October 2010 and March 2012, cytol

115 rgeons (>100 cases per year) performed 5% of thyroidectomies, but 90% of their patients were white (P

116 esda criteria, and 1 or more indications for thyroidectomy by 2009 American Thyroid Association guide

117 d superior laryngeal nerve injury during her thyroidectomy by Arnold Kegel, MD, in 1935, resulting in

118 Discussion: Radioactive iodine therapy after thyroidectomy can successfully ablate residual thyroid r

119 Thyroidectomy caused a 25% reduction in olfactory GST al

120 e internal jugular vein (IJV) after subtotal thyroidectomy caused by local recurrence of papillary th

121 f the parathyroids in situ during preventive thyroidectomy combined with selective CND based on preop

122 Graves disease (GD) is lower after subtotal thyroidectomy compared to total thyroidectomy (TT).

123 e a survival advantage associated with total thyroidectomy compared with lobectomy.

124 esophagectomy, gastrectomy, pancreatectomy, thyroidectomy, coronary artery bypass graft surgery, and

125 Surgical Quality Improvement Program (NSQIP) thyroidectomy data from January 1, 2016, to December 31,

126 dies have indicated that total or near-total thyroidectomy decreases overall recurrence rate.

127 Thyroidectomy done at no later than 1 year of age is ass

128 surgeon meets the high-volume threshold for thyroidectomies early in their career, but does not reac

129 Twenty-five thyroidectomy explorations in 15 patients were monitored

130 After total thyroidectomy followed by radioiodine ablation, 61 conse

131 ng surveillance for recurrent disease, total thyroidectomy followed by RAI appears to be the most ben

132 were treated initially with total/near-total thyroidectomy, followed by remnant RAI ablation with eit

133 Another patient underwent delayed completion thyroidectomy for a contralateral lobe malignant abnorma

134 Patients undergoing thyroidectomy for benign disease were allocated by a blo

135 us recommendations have historically advised thyroidectomy for definitive diagnosis.

136 The extent of primary thyroidectomy for differentiated thyroid cancer is contr

137 nt ablation (RRA) is frequently used after a thyroidectomy for differentiated thyroid carcinoma becau

138 indings involving 166 patients who underwent thyroidectomy for differentiated thyroid carcinoma was p

139 o received outpatient 131I therapy following thyroidectomy for differentiated thyroid carcinoma were

140 Following thyroidectomy for differentiated thyroid carcinoma, 50 p

141 or radioablation of thyroid remnants after a thyroidectomy for differentiated thyroid carcinoma.

142 previously had undergone total or near-total thyroidectomy for differentiated thyroid carcinoma.

143 eria were an age of 18 years or older; total thyroidectomy for differentiated thyroid carcinoma; tumo

144 18 to 65 years who were scheduled for total thyroidectomy for goiter, benign nodular disease, suspec

145 Most experienced surgeons recommend total thyroidectomy for Hurthle cell carcinomas and reserve th

146 A rising calcitonin level after total thyroidectomy for localized disease generally indicates

147 l metastatic lymph nodes (N1a) after partial thyroidectomy for localized well-differentiated thyroid

148 e parathyroid glands resected at the time of thyroidectomy for medullary thyroid carcinoma and transp

149 Seventy-three patients underwent thyroidectomy for palpable MTC with immediate or delayed

150 Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcin

151 Many patients undergoing thyroidectomy for papillary thyroid carcinoma (PTC) have

152 used to better define the optimal extent of thyroidectomy for patients with thyroid cancer.

153 Consensus guidelines have recommended total thyroidectomy for PTC > or =1 cm; however, no study has

154 is the first study to demonstrate that total thyroidectomy for PTC > or =1.0 cm improves outcomes.

155 d patients 18 years or younger who underwent thyroidectomy for PTC from 2010 to 2020 at 3 tertiary pe

156 Guidelines recommend total thyroidectomy for PTC tumors >1 cm, based on older data

157 Current guidelines suggest total thyroidectomy for PTC tumors >1 cm.

158 stigate if MT use for FN directs appropriate thyroidectomy for TC while triaging to surveillance nodu

159 tive series of 1510 patients who had initial thyroidectomy for TC with routine testing for BRAF, RAS,

160 Current guidelines recommend total thyroidectomy for the majority of pediatric thyroid canc

161 hyroid carcinoma and performing prophylactic thyroidectomy for the prevention or cure of this disease

162 damage to the parathyroid gland during total thyroidectomy for toxic goiter.

163 was associated with a 26% increased rate of thyroidectomy for treating thyroid cancer.

164 ns were obtained from 29 women who underwent thyroidectomy for various thyroid disorders.

165 oid glands resected or devascularized during thyroidectomy for well-differentiated thyroid carcinoma

166 All records of thyroidectomies from the First Affiliated Hospital of Na

167 9 patients who underwent total or completion thyroidectomy from December 2015 to June 2023.

168 ed with lobectomy, patients undergoing total thyroidectomy had more nodal (7% vs 27%), extrathyroidal

169 The authors have addressed whether total thyroidectomy has a survival benefit justifying its use

170 outcome association has been established for thyroidectomy; however, a threshold number of cases defi

171 Severe post-thyroidectomy hypocalcemia can be life-threatening; data

172 Total thyroidectomy improved health-related quality of life an

173 Total or near-total thyroidectomy improved overall survival (risk ratio [RR]

174 on form of thyroid carcinoma detected during thyroidectomies in China while other features of thyroid

175 s performed in 56 patients, near or subtotal thyroidectomy in 47 patients and lobectomy in 55 patient

176 An incidental cancer was found at thyroidectomy in a nonvisualized nodule.

177 We sought to determine whether total thyroidectomy in asymptomatic young members of kindreds

178 Prophylactic thyroidectomy in hereditary cases of MTMC may be guided

179 Total thyroidectomy in high-risk patients with differentiated

180 ional analysis of all patients who underwent thyroidectomy in Maryland between 1991 and 1996 was cond

181 ed by the increased use of total or subtotal thyroidectomy in patients with advanced disease.

182 All patients who underwent total thyroidectomy in Sweden from 2005 to 2015 were identifie

183 Patients who underwent thyroidectomy in the American College of Surgeons-Nation

184 t survival difference according to extent of thyroidectomy in the intermediate or high-risk groups ei

185 tients with PTC tumors 1.0-4.0 cm undergoing thyroidectomy in the National Cancer Database, 1998-2006

186 ed with a 26% increased rate of undergoing a thyroidectomy (incident rate ratio, 1.26; 95% CI, 1.04-1

187 0.5% for subtotal thyroidectomy to 12.5% for thyroidectomy involving neck dissections).

188 Thyroid disease is common, and thyroidectomy is a mainstay of treatment for many benign

189 Total thyroidectomy is an option in selected cases.

190 ify a tumor size threshold above which total thyroidectomy is associated with an improvement in recur

191 Overall, thyroidectomy is associated with favorable outcomes, par

192 eshold could be identified above which total thyroidectomy is associated with improved outcomes.

193 Determining the correct extent of initial thyroidectomy is challenging.

194 These findings suggest that, although thyroidectomy is considered safe, significant racial dis

195 Management of the parathyroids during thyroidectomy is controversial.

196 Thyroidectomy is effective and is the only measure that

197 or targeted molecular therapies.Prophylactic thyroidectomy is indicated early in life for RET mutatio

198 This suggests that the general use of total thyroidectomy is not indicated, except in highly selecte

199 and the circumstances in which prophylactic thyroidectomy is reasonable to consider as part of hered

200 d (131)I(-) treatment of thyroid cancer post-thyroidectomy is the most effective targeted internal ra

201 Total or near-total thyroidectomy is the treatment of choice in patients wit

202 ndex hernia repair, primary total or partial thyroidectomy, laparoscopic cholecystectomy, or laparosc

203 nditions, Goiter, Adjuncts and Approaches to Thyroidectomy, Laryngology, Familial Thyroid Cancer, Pos

204 who develop first-side LOS, immediate total thyroidectomy may be considered among those who have pre

205 However, aborting planned total thyroidectomy may lead to persistence of symptoms, delay

206 Completion thyroidectomy may not be necessary in appropriately sele

207 Among 400 patients undergoing planned total thyroidectomy (mean age, 50.5 years [range, 4-88 years];

208 lead to increased AF vulnerability in a rat thyroidectomy model.

209 I uptake and MPA for initial treatment after thyroidectomy (n = 39), including 17 patients with compr

210 After total thyroidectomy, no patient in either group developed perm

211 were significantly associated with risks of thyroidectomy (odds ratio [OR], 6.0; 95% CI, 2.2-16.3; P

212 s of experiencing a 30-day readmission after thyroidectomy [odds ratio (OR) 0.70, 95% confidence inte

213 tween 1993 and 2000, we performed preventive thyroidectomies on 50 patients with MEN2A (group A).

214 PTU treatment, T(4) replacement therapy and thyroidectomy on GST expression, GST and glutathione per

215 ity was manipulated by surgical and chemical thyroidectomy on the one hand, and by thyroxine (T(4)) a

216 garding patient demographics, indication for thyroidectomy, operative procedure, pathologic diagnoses

217 low-risk PTC who were offered the choice of thyroidectomy or active surveillance.

218 mulating hormone (TSH) elevation after total thyroidectomy or after discontinuation of thyroxine (T(4

219 f FNA specimens may help to avoid diagnostic thyroidectomy or may help in deciding the extent of surg

220 Total thyroidectomy or medical management with hormone substit

221 reated with oral antithyroid drugs, surgical thyroidectomy, or (131)I-iodide.

222 Surgeons were categorized by volume of thyroidectomies over the 6-year study period: A (1 to 9

223 Surgeons who recommend total thyroidectomy over lobectomy for subcentimeter unifocal

224 ting an overall survival advantage for total thyroidectomy over lobectomy.

225 ia was more frequent after total or subtotal thyroidectomy (p = 0.001) while wound complications incr

226 th or without reconstruction, parotidectomy, thyroidectomy, parathyroidectomy, laryngectomy, or trans

227 Scan identified adult patients who underwent thyroidectomy, parathyroidectomy, neck dissections for t

228 One hundred twenty-two consecutive post-thyroidectomy patients for differentiated thyroid carcin

229 ocalcemia occurred in 5.8% (n = 428) of 7366 thyroidectomy patients, with 83.2% necessitating intrave

230 al protocol for imaging and ablation of post-thyroidectomy patients.

231 Following thyroidectomy, patients were prescribed LT4.

232 sociation between the number of annual total thyroidectomies per surgeon and risk of complications.

233 To determine the number of total thyroidectomies per surgeon per year associated with the

234 OBJECTIVE:: To determine the number of total thyroidectomies per surgeon per year associated with the

235 ence interval 1.47-2.01], center-volume <100 thyroidectomies per year (OR 1.22; 1.03-1.44), age above

236 ded (FFPE) tissues from sequential pediatric thyroidectomies performed between January 2003 and Decem

237 tree economic model was developed to compare thyroidectomies performed with autofluorescence to visua

238 comes of Surgery, Preoperative Care, Initial Thyroidectomy, Perioperative Tissue Diagnosis, Nodal Dis

239 comes of Surgery, Preoperative Care, Initial Thyroidectomy, Perioperative Tissue Diagnosis, Nodal Dis

240 te a more complete operative plan, including thyroidectomy, possible lymphadenectomy, and postoperati

241 nch of the vagus nerve may be injured during thyroidectomy, producing vocal defects more subtle than

242 n-Short Form and Surgical Fear (referring to thyroidectomy) questionnaires.

243 Change in the thyroidectomy rate for thyroid cancer treatment was the

244 t-subsidized or self-pay insurance had lower thyroidectomy rates for thyroid cancer in Massachusetts

245 Does dexamethasone given before thyroidectomy reduce postoperative nausea and vomiting (

246 Even though conventional thyroidectomy remains in the gold standard for thyroidec

247 Thyroidectomy remains the mainstay of treatment for thyr

248 ic efficacy of (131)I given to ablate a post-thyroidectomy remnant.

249 results of this study demonstrate that total thyroidectomy results in lower recurrence rates and impr

250 ients with MEN2A treated by preventive total thyroidectomy routine total parathyroidectomy with autot

251 ll localized lesions while total or subtotal thyroidectomy should be considered for more extensive tu

252 in complication rates, near-total and total thyroidectomy should be offered to patients with well-di

253 Total thyroidectomy should be used in gene carriers without cl

254 esearchers advocate partial and others total thyroidectomy; some advocate prophylactic central cervic

255 had complete (R0) resection following total thyroidectomy; stage pT1, pT2, pT3 (according to Tumour,

256 ational Surgical Quality Improvement Program thyroidectomy-targeted database (2016-2017) were abstrac

257 isk differentiated thyroid cancer undergoing thyroidectomy, the postoperative administration of radio

258 ular carcinoma of the thyroid received total thyroidectomy; this was followed by thyroid hormone with

259 d RET allele, can be managed by prophylactic thyroidectomy, thus preventing the development of medull

260 oidism was induced in adult rats by surgical thyroidectomy; thyroid status was manipulated in culture

261 y diagnosis and procedure (0.5% for subtotal thyroidectomy to 12.5% for thyroidectomy involving neck

262 The mean interval from initial thyroidectomy to palliative surgery was 5.8 +/- 1.5 year

263 rentiated thyroid cancer who were undergoing thyroidectomy to receive ablation with postoperative adm

264 laparoscopic appendectomy, hemorrhoidectomy, thyroidectomy, transurethral prostate surgery, parathyro

265 ents with cN0 PTC were randomized to a total thyroidectomy (TT) or a TT+ pCND.

266 ter subtotal thyroidectomy compared to total thyroidectomy (TT).

267 3), but not cortisol, was prevented by fetal thyroidectomy (TX).

268 Consecutive patients scheduled for total thyroidectomy using IONM were included.

269 of functioning residual thyroid tissue after thyroidectomy using radioiodine whole-body (WB) imaging

270 val was similar in patients undergoing total thyroidectomy versus lobectomy for tumors 1.0-4.0 cm [ha

271 utine parathyroid autotransplantation during thyroidectomy virtually eliminates postoperative hypopar

272 The natural history of post-thyroidectomy voice disturbances for patients with prese

273 laryngeal nerve injury appear to alter post-thyroidectomy voice.

274 hypoparathyroidism after total or completion thyroidectomy was 15% in patients who were referred to u

275 patients who underwent immediate completion thyroidectomy was also identified and reviewed.

276 treated with radioactive iodine after total thyroidectomy was assessed with multivariable weighted r

277 Diagnostic thyroidectomy was avoided in 87 (51%) patients tested wi

278 Thyroidectomy was done before the age of 1 year in 20 pa

279 Total or near-total thyroidectomy was done in 85.3% of patients with papilla

280 ypocalcemia increased when total or subtotal thyroidectomy was done.

281 of permanent hypoparathyroidism after total thyroidectomy was high and associated with parathyroid a

282 When MT was positive, thyroidectomy was more often utilized (91% v.

283 Total thyroidectomy was performed in 56 patients, near or subt

284 All adult patients referred for total thyroidectomy were assessed for eligibility (n = 90).

285 roid cancer, and all-cause mortality without thyroidectomy were assessed using proportions with exact

286 Adults undergoing total thyroidectomy were identified from the Health Care Utili

287 A total of 44 265 patients undergoing thyroidectomy were included (77.2% female; mean [SD] age

288 to be observed without immediate completion thyroidectomy were included.

289 patients who underwent immediate completion thyroidectomy were reviewed.

290 tients who had undergone near-total or total thyroidectomy, which suggests that T3 administration is

291 Among patients planned for total thyroidectomy who develop first-side LOS, immediate tota

292 Total thyroidectomy with 'therapeutic' cervical lymph node dis

293 ent studies performed on patients undergoing thyroidectomy with coexisting Hashimoto's thyroiditis re

294 equally strong advocates of less aggressive thyroidectomy with its lower hazard of parathyroid and r

295 Therefore, total thyroidectomy with left neck dissection and segmental re

296 yroidectomy remains in the gold standard for thyroidectomy with low morbidity and excellent outcomes,

297 1-cm papillary thyroid cancer who underwent thyroidectomy with one or more lymph nodes (LNs) examine

298 and included patients with MTC who underwent thyroidectomy with preoperative imaging.

299 lary thyroid carcinoma, near-total and total thyroidectomy with routine central and bilateral functio

300 entify a surgeon volume threshold (>25 total thyroidectomies/y) that is associated with improved pati